A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants

Summary

This is a first in human Phase 1 study to evaluate the safety, tolerability and pharmacokinetics with healthy young and elderly adult male volunteers after receiving single and multiple ascending dose of BEY2153.

Timeline

Start

2020-08-27

Primary completion

2021-11-23

Completion

2021-11-23

Drugs

Indications